Product Information
FENOFIBRATE 134 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1141 per EA under NDC 62332008531. Its NADAC has been published 243 times since Nov 3, 2021.
Strength
134 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332008531
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA213842On Market Since
10/22/2020
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 134 MG CAPSULE has been published 243 times since Nov 3, 2021, and over the history we have for it it has declined 47.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1141 per EA |
|---|---|
| All-time high | $0.2172 (Nov 10, 2021) |
| All-time low | $0.1020 (Nov 20, 2024) |
| 52-week high | $0.1391 |
| 52-week low | $0.1101 |
| Median price | $0.1328 |
| Average price | $0.1343 |
| Largest weekly change | -28.2% (Feb 21, 2024) |
| Weeks tracked | 243 |
| Tracking since | Nov 3, 2021 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 134 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 134 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $0.1141 per EA (NDC 62332008531), effective Jun 24, 2026.
How has the price of FENOFIBRATE 134 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 134 MG CAPSULE has declined 47.4%. It has been tracked across 243 weekly CMS publications since Nov 3, 2021.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 134 MG CAPSULE?
Since Nov 3, 2021, the NADAC for FENOFIBRATE 134 MG CAPSULE has ranged from a low of $0.1020 (Nov 20, 2024) to a high of $0.2172 (Nov 10, 2021), with a median of $0.1328 per EA.
Are there cheaper alternatives to FENOFIBRATE 134 MG CAPSULE?
5 NADAC-published products share the same active ingredient, strength, and dosage form as FENOFIBRATE 134 MG CAPSULE, but none are currently priced below it.
Who manufactures FENOFIBRATE 134 MG CAPSULE?
FENOFIBRATE 134 MG CAPSULE (NDC 62332008531) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification